The research into the drug, ketamine, could change palliative care treatment worldwide. For decades it has been used as an anaesthetic in both human and veterinary medicine. But its use in treating dying cancer patients has been called into question by researchers.
FULL ARTICLE AT Australian Broadcasting Corporation